skip navigationU S P T O SealUnited States Patent and Trademark Office TTABVUE logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.1

Extension of Time

Number:75981626Filing Date:08/02/2004
Status:TerminatedStatus Date:02/16/2005
General Contact Number:571-272-8500
Paralegal Name:KARL S KOCHERSPERGER
Opposition #:91163802 91164007
Defendant
Name:Alara Healthcare Corporation
Correspondence:PETER S. SLOANE
OSTROLENK, FABER, GERB & SOFFEN, LLP
1180 AVENUE OF THE AMERICAS
NEW YORK, NY 10036-8403
UNITED STATES

 
Serial #:75981626Application FileAssignment
Application Status: Abandoned - No Statement Of Use Filed
Mark: ALARA
Potential Opposer
Name:Alara, Inc.
Correspondence:Lisa Greenwald-Swire
Heller Ehrman White & McAuliffe LLP
275 Middlefield Road
Menlo Park, CA 94025-3506
UNITED STATES
sv-trademark@hewm.com
Phone: 650-324-7000
 
Opposition #:91163802
Serial #:78157017Application FileAssignmentRegistration #:2917181
Application Status: Cancelled - Section 8
Mark: ALARA
Granted To Date:01/16/2005
Potential Opposer
Name:3M COMPANY
Correspondence:LOUIS T. PIRKEY
FULBRIGHT & JAWORSKI LLP
600 CONGRESS AVENUE, SUITE 2400
AUSTIN, TX 78701
UNITED STATES

 
Opposition #:91164007
Granted To Date:11/17/2004
Potential Opposer
Name:MERRELL PHARMACEUTICALS INC.
Correspondence:Margaret H. Bitler
Aventis Pharmaceuticals Inc.
Route #202-206 North / Box 6800 (Mail Stop: BW-D-335)
Bridgewater, DE 08807-0800
UNITED STATES
susan.chwatmyers@aventis.com
Phone: 908-231-2626
Granted To Date:11/17/2004
Prosecution History
#DateHistory Text
810/27/2004EXTENSION OF TIME GRANTED
710/27/2004INCOMING - EXT TIME TO OPPOSE FILED
608/31/2004EXTENSION OF TIME GRANTED
508/23/2004INCOMING - EXT TIME TO OPPOSE FILED
408/16/2004EXTENSION OF TIME GRANTED
308/16/2004INCOMING - EXT TIME TO OPPOSE FILED
208/02/2004EXTENSION OF TIME GRANTED
108/02/2004INCOMING - EXT TIME TO OPPOSE FILED
Results as of 04/21/2021 08:21 AM
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY POLICY